Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$66.18 - $83.18 $18,265 - $22,957
276 New
276 $21,000
Q3 2020

Nov 13, 2020

SELL
$85.07 - $109.69 $425,349 - $548,450
-5,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$74.18 - $108.93 $370,900 - $544,650
5,000 New
5,000 $520,000
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $27.7 Million - $33 Million
-380,999 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $864,815 - $1.04 Million
-11,763 Reduced 2.99%
380,999 $32.4 Million
Q1 2019

May 14, 2019

BUY
$63.56 - $88.17 $23.6 Million - $32.7 Million
370,762 Added 1685.28%
392,762 $33.8 Million
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $117,000 - $139,880
2,000 Added 10.0%
22,000 $1.4 Million
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $5.65 Million - $6.79 Million
-91,450 Reduced 82.05%
20,000 $1.38 Million
Q2 2018

Jul 19, 2018

BUY
$60.85 - $83.98 $4.96 Million - $6.85 Million
81,535 Added 272.56%
111,450 $7.47 Million
Q1 2018

May 10, 2018

SELL
$83.06 - $100.98 $4.79 Million - $5.82 Million
-57,675 Reduced 65.85%
29,915 $2.49 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $59.7 Million - $74.4 Million
-638,270 Reduced 87.93%
87,590 $8.3 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $79.2 Million - $100 Million
725,860
725,860 $84.7 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.